Rights and permissions
About this article
Cite this article
Dasatinib good news in chronic-phase CML. Inpharma Wkly. 1619, 12 (2008). https://doi.org/10.2165/00128413-200816190-00027
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816190-00027